We used a two-pronged approach to target Itch in a mouse model for AD: (1) adeno-associated virus (AAV) expressing loss-of-function mutants of Itch and (2) clomipramine, a tricyclic antidepressant, which is an Itch inhibitor. The gene discussed is ITCH; the disease is Alzheimer disease.